Delivery Order SPE2DB22D3501-SPE2DB24FVB76
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Gralise ER 600 mg tablets (90-count) with a ceiling value of $3,305.61. The delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical, is scheduled for completion by December 16, 2025. This non-set-aside award was made competitively through the federal...
- This is a $20,529.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4565353869 GRALISE ER 600 MG TABLET 90S, a prescription pharmaceutical product. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to supply a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,314.97, is for the delivery of the pharmaceutical product Gralise ER 600 mg tablets. The contract has a firm fixed price and is set to expire on April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office division is a major supplier of pharmaceutical products and medical supplies...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Gralise ER 600 mg tablets, a medication used for the treatment of neuropathic pain. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,970.45 and an ultimate completion date of April 25, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor, and the contract does...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Gralise ER 600 mg tablets. The order, valued at $3,343.19, has a firm-fixed price and an ultimate completion date of August 1, 2024. Amerisourcebergen, through its Corporate Office division, is a for-profit organization that has been awarded numerous federal contracts to provide a wide range of essential medical...
- This federal contract award is for the delivery of Gralise ER 300 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,209.43. The contract has a period of performance through December 13, 2024 and utilizes a firm fixed-price pricing structure. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 600 MG TABLET 90S. The contract has a ceiling value of $7,263.41 and a performance period through August 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a prominent supplier of pharmaceutical products and medical supplies to various federal agencies, including the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of GRALISE ER 300 mg tablets (90-count packages) with a contract value of $1,479.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the company's...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,783.79, is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 15, 2023. AmerisourceBergen holds a significant...